A SBT-based Protocol-directed Program in Difficult-to-Wean Patients
A Spontaneous Breathing Trial-based Protocol-directed Program in Difficult-to-Wean Patients
1 other identifier
interventional
200
1 country
1
Brief Summary
Weaning patients from a ventilator is one of the most challenging processes in an intensive care unit. The investigators aimed to determine whether spontaneous breathing trial (SBT)-based protocol-directed weaning combined with the high-flow nasal cannula (HFNC) could be superior to routine SBT-based weaning in reducing the duration of mechanical ventilation (MV) in difficult-to-wean patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 30, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedSeptember 10, 2021
September 1, 2021
3 years
August 30, 2021
September 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mechanical ventilation days
the duration of mechanical ventilation
60 days
Secondary Outcomes (1)
re-intubated within 24 hours
24 hours
Study Arms (2)
weaning protocol group
EXPERIMENTALspontaneous breathing trial (SBT)-based protocol-directed weaning combined with the high-flow nasal cannula group
routine SBT weaning group
NO INTERVENTIONInterventions
a weaning protocol that is combined spontaneous breathing trial (SBT) with the high-flow nasal cannula (HFNC)
Eligibility Criteria
You may qualify if:
- age ≥ 16 years old
- MV for more than 48 hours
- intubated or tracheostomized
You may not qualify if:
- pregnancy
- irreversible respiratory failure caused by neurodegenerative disorders, such as Alzheimer disease, motor neuron disease, or multiple system atrophy
- pre-existing decision to limit life support
- waiving of MV during treatment
- terminal stage of severe illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- JinyanXinglead
Study Sites (1)
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266555, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 30, 2021
First Posted
September 5, 2021
Study Start
January 1, 2019
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
September 10, 2021
Record last verified: 2021-09